Skin Analytics raises £4M Series A to use AI for skin cancer screening – TechCrunch

Skin Analytics, a U.K.-based startup that has developed a skin cancer screening service that uses artificial intelligence, has raised £4 million in Series A funding. The round was led by Hoxton Ventures, with participation from Nesta and Mustard Seed Ventures. Skin Analytics says it will use the injection of cash to expand its focus to the U.S. after it was awarded the "Breakthrough Device Designation" by the FDA, as part of a programme designed to fast track new technologies that can have significant impact on the nation's health. It will also continue forging partnerships within the U.K.'s national health service, following the launch of what it claims was the world's first "AI-powered" clinical pathway in conjunction with University Hospital Birmingham. Skin Analytics offers a CE marked medical device that studies suggests is able to identify skin cancers, pre-cancerous and benign lesions "to the same level as a dermatologist".